Patients with advanced cancer often experience frequent and prolonged hospitalizations; however, the factors associated with greater health care utilization have not been described. We sought to investigate the relation between patients' physical and psychological symptom burden and health care utilization. METHODS: We enrolled patients with advanced cancer and unplanned hospitalizations from September 2014-May 2016. Upon admission, we assessed physical (Edmonton Symptom Assessment System [ESAS]) and psychological symptoms (Patient Health Questionnaire 4 [PHQ-4]). We examined the relationship between symptom burden and healthcare utilization using linear regression for hospital length of stay (LOS) and Cox regression for time to first unplanned readmission within 90 days. We adjusted all models for age, sex, marital status, comorbidity, education, time since advanced cancer diagnosis, and cancer type. RESULTS: We enrolled 1,036 of 1,152 (89.9%) consecutive patients approached. Over one-half reported moderate/severe fatigue, poor well being, drowsiness, pain, and lack of appetite. PHQ-4 scores indicated that 28.8% and 28.0% of patients had depression and anxiety symptoms, respectively. The mean hospital LOS was 6.3 days, and the 90-day readmission rate was 43.1%. Physical symptoms (ESAS: unstandardized coefficient [B], 0.06; P < .001), psychological distress (PHQ-4 total: B, 0.11; P 5 .040), and depression symptoms (PHQ-4 depression: B, 0.22; P 5 .017) were associated with longer hospital LOS. Physical (ESAS: hazard ratio, 1.01; P < .001), and anxiety symptoms (PHQ-4 anxiety: hazard ratio, 1.06; P 5 .045) were associated with a higher likelihood for readmission. CONCLUSIONS: Hospitalized patients with advanced cancer experience a high symptom burden, which is significantly associated with prolonged hospitalizations and readmissions. Interventions are needed to address the symptom burden of this population to improve health care delivery and utilization. Cancer 2017;123:4720-7.
INTRODUCTION
Patients with advanced cancer use substantial health care resources, and recent trends suggest that rates of health care utilization are increasing. 1, 2 Hospitalizations account for a significant proportion of this health care use. Over one-half of patients with cancer are admitted to the hospital at least once during their last month of life, and nearly 10% experience a hospital readmission during this time. 1, [3] [4] [5] [6] Importantly, patients with advanced cancer often prefer to avoid hospitalizations, especially near the end of life, yet many still die in the hospital. 3, [7] [8] [9] Thus, there is a critical need to explore factors that may contribute to the rising healthcare utilization in patients with advanced cancer.
Hospital admissions are not only inconsistent with patients' preferences, but incur significant costs. 10 Rising health care costs represent a major challenge in the United States, affecting both patients and providers. 11, 12 Medical care for patients in their last year of life accounts for >25% of Medicare spending, and over one-half of these costs occur in the last 60 days of elife. 13, 14 Notably, hospitalizations represent the largest component of health care spending for patients with cancer. 15, 16 Both long hospital stays 17 and readmissions cost the health care system billions of dollars each year. 18 Consequently, programs like the Hospital Readmissions Reduction Program and value-based purchasing models, including accountable care organizations, have placed a considerable emphasis on decreasing the use of health care services, particularly hospital length of stay and readmissions. [19] [20] [21] [22] Patients with cancer often require hospitalizations for physical symptoms, such as pain, [23] [24] [25] [26] fever, 23, 24 dyspnea, 24, 25 and fatigue. 26 However, much of the existing literature on symptom prevalence and severity in patients with cancer has focused primarily on those in the ambulatory care setting, with very little attention to either the physical or psychological symptom burden of hospitalized patients. [27] [28] [29] [30] [31] It is important to note that the relation between patients' physical and psychological symptoms and their hospital length of stay and risk of readmissions is currently unknown. Developing a more comprehensive understanding of the symptom burden of hospitalized patients with advanced cancer and their relation to patients' health care use is an essential first step to enhancing the quality of life and care for this population. By identifying potentially modifiable factors, hospital lengths of stay and readmissions in oncology may be reduced.
In the current study, we prospectively collected patients' self-reported symptom burden to comprehensively describe the physical and psychological symptoms of hospitalized patients with advanced cancer and to explore the relation between their symptoms and health care utilization. We hypothesized that patients with higher physical and psychological symptoms would have longer hospital lengths of stay and greater risk for unplanned readmissions compared with those who reported lower symptom burden.
MATERIALS AND METHODS

Study Procedures
This study was approved by the Dana-Farber/Harvard Cancer Center Institutional Review Board. From September 2, 2014, to May 6, 2016, we enrolled 1036 patients with advanced cancer who had an unplanned hospital admission at Massachusetts General Hospital (MGH) in a longitudinal cohort study. We identified and recruited consecutive patients who had an unplanned hospital admission (index hospitalization) during the study period by screening the daily inpatient oncology census. Each participant contributed 1 unique hospitalization. A research assistant obtained written, informed consent from eligible patients on the first weekday following admission (within 2-5 days of hospitalization). After consent was obtained, participants completed a symptom burden questionnaire.
Participants
Patients were eligible for study participation if they were aged 18 years and admitted to MGH with a known diagnosis of advanced cancer. We defined patients with advanced cancer as those not being treated with curative intent. We identified patients not being treated with curative intent based on the chemotherapy order entry treatment intent designation (palliative vs. curative), or based on documentation in the oncology clinic notes for those not receiving chemotherapy. Study participants also had to be able to read and respond to study questionnaires in English or with minimal assistance from an interpreter. We excluded patients with elective or planned hospital admissions, defined as hospitalizations for chemotherapy administration, scheduled surgical procedures, or chemotherapy desensitization. We also excluded patients with leukemia and those who were admitted for stem cell transplantation.
Study Measures
Sociodemographic and clinical factors
Each patient registering for care at MGH is required to provide demographic information, which is documented in the demographics section of the electronic health record (EHR). We reviewed the demographics section of the EHR to obtain participants' date of birth, sex, race, relationship status, education, and religion. We also reviewed patients' oncology clinic notes in the EHR to determine the Charlson Comorbidity Index, date of diagnosis with advanced cancer, and cancer type.
Patient-reported symptom burden
We used a modified version of the self-administered, revised Edmonton Symptom Assessment System (ESASr) to assess patients' symptoms. 32 The ESAS-r assesses pain, fatigue, drowsiness, nausea, appetite, dyspnea, depression, anxiety, and well being over the previous 24 hours. We also included constipation, as this is a highly prevalent symptom in patients with advanced cancer. 33 Individual symptoms are scored on a scale from 0 (reflecting absence of the symptom) to 10 (reflecting the worst possible severity). Consistent with prior research, we scored the severity of ESAS scores as 0 (none), 1 to 3 (mild), 4 to 6 (moderate), and 7 to 10 (severe). 34 We computed the composite ESAS physical and total symptom variables that included scores of patients' physical symptoms (pain, fatigue, drowsiness, nausea, appetite, dyspnea, constipation) and total symptoms (pain, fatigue, drowsiness, nausea, appetite, dyspnea, depression, anxiety, well being, constipation). The ESAS physical and total symptom scores are well validated and have been used previously in the oncology setting, with minimal clinically important differences of 3 points for each of these composite scores. 32, 35 To assess patients' psychological symptoms, we used the Patient Health Questionnaire-4 (PHQ-4), 36, 37 which is a 4-item tool that contains two 2-item subscales assessing depression and anxiety symptoms. Both subscales and the composite PHQ-4 score can also be evaluated continuously, with higher scores indicating worse psychological distress. 36 Scores on each subscale range from 0 to 6, with scores 3 denoting clinically significant depression or anxiety. 36 We added the PHQ-4 to the study questionnaires on November 15, 2014, to have a validated measure specifically for psychological distress rather than the single depression and anxiety items of the ESAS-r.
Outcome Measures
The primary outcome of the study was hospital length of stay, which we defined as the number of days from hospital admission to hospital discharge. The secondary outcome focused on unplanned hospital readmissions. To account for mortality, as patients who die after their index hospitalization have less time at risk for readmission, we used the time to first unplanned admission within 90 days of hospital discharge as the outcome measure, defined as the number of days from hospital discharge to the first unplanned readmission within 90 days. We censored patients without a readmission at their 90-day postdischarge date and those who died within 90 days at their death date. In addition, we created a composite dichotomous outcome categorizing patients as dead and/or readmitted within 90 days (yes vs no) versus those who were alive and had no readmissions within 90 days to account further for early mortality.
Statistical Analysis
We used descriptive statistics to evaluate the frequencies, means, and standard deviations (SDs) for participants' characteristics and symptom burden. To investigate the relationship between physical and psychological symptoms and hospital length of stay, we computed linear regression models adjusted for age, sex, marital status, education level, comorbidities (Charlson Comorbidity Index), time since advanced cancer diagnosis, and cancer type. Given collinearity between physical and psychological symptoms, we created separate models for each of the following: PHQ-4 total score (total psychological distress), PHQ-4 depression subscale, PHQ-4 anxiety subscale, ESAS physical score, ESAS total score, ESAS depression score, and ESAS anxiety score. We used Cox proportional-hazards regression models adjusted for the same variables described above to assess the relation between physical and psychological symptoms and the time to readmission within 90 days. Finally, we used logistic regression models adjusted for the same variables described above to assess the relationship between physical and psychological symptoms and the odds of death or readmission within 90 days.
With a sample size of 1000 patients, the study has >95% power to detect a 0.2 difference in hospital length of stay in days for a 1-point increase in symptom burden, as measured by the ESAS, and a 1-point increase in psychological distress, as measured by the PHQ-4, with a 2-sided a of .05. Less than 1% of patients had missing data for each individual symptom, precluding the need for missing data imputations. All reported P values are 2-sided, and P < .05 is considered statistically significant. We used the Stata version 9.3 software package (Stata Corporation, College Station, Texas) for all statistical analyses.
RESULTS
Participant Sample
In total, we screened 2353 patients for eligibility (Fig. 1 common cancer type (32.0%), and participants had a mean time since diagnosis of advanced cancer of 510.01 6 SD5722.66 days. Participants had a mean hospital length of stay of 6.26 6 SD54.82 days. The 90-day readmission rate was 43.1%, and the 90-day mortality rate was 41.6%. Nearly two-thirds of participants (65.0%) died or were readmitted within 90 days. Figure 2 depicts the severity of symptom burden in hospitalized patients with advanced cancer. Over one-half of patients reported moderate/severe fatigue (86.7%), poor well being (74.2%), drowsiness (71.7%), pain (67.7%), and lack of appetite (67.3%). Of the 10 ESAS symptoms we evaluated, patients reported experiencing a mean 6 SD of 5.76 6 2.38 moderate/severe symptoms. In our sample, only 17 patients (1.7%) reported experiencing no moderate/severe symptoms. More than one-quarter of participants had clinically significant symptoms of depression (28.8%) and anxiety (28.0%) based on their PHQ-4 scores. .012) were all significantly associated with a higher likelihood of death or readmission within 90 days (Table 4) .
Patient-Reported Symptom Burden
The Relationship Between Symptom Burden and Hospital Length of Stay
DISCUSSION
In the current study, we demonstrated that hospitalized patients with advanced cancer experience an immense physical and psychological symptom burden, with >50% reporting moderate-to-severe physical symptoms, such as fatigue, pain, drowsiness, and poor appetite. Notably, >25% of patients also reported clinically significant depression and anxiety symptoms. Moreover, hospitalized patients' physical and psychological symptoms were significantly associated with longer hospital length of stay and greater risk for unplanned hospital readmissions within 90 days. Collectively, these findings underscore the prevalence and severity of symptoms experienced by hospitalized patients with cancer and illustrate the patterns of health care utilization within this highly symptomatic population.
To our knowledge, this is the first study to demonstrate the relation between patients' self-reported physical symptoms and health care utilization among hospitalized patients with advanced cancer. Patients' physical symptom burden was significantly associated with both their hospital length of stay and their risk of unplanned hospital readmission within 90 days. As previous studies have demonstrated that patients' symptoms may result in hospital admissions, 23, 24 our investigation provides novel insights to help clinicians and policymakers critically assess the potential contribution of uncontrolled symptoms to excessive and costly cancer care. Interventions such as symptom monitoring and the integration of Original Article patient-reported outcomes into routine processes of care are promising strategies to reduce symptom burden and enhance patient-reported outcomes. 38, 39 Future research should also focus on testing the potential efficacy of such interventions on reducing patients' use of health care services.
Interestingly, we also observed that patients' psychological symptoms were significantly associated with their hospital length of stay and their risk of unplanned readmissions. Although studies of patients with cardiovascular and pulmonary disease have reported an association between psychological distress and increased use of health care services, [40] [41] [42] [43] no prior investigations have explored this relationship among hospitalized patients with advanced cancer. Given the proportion of patients with depression and anxiety symptoms in the current sample, these findings are noteworthy. Possible explanations for the relation between psychological distress and increased health care use include the tendency for individuals with psychological distress to present with multiple physical complaints. [44] [45] [46] In addition, depression and anxiety symptoms may influence patients' health behaviors, including treatment nonadherence, which, in turn, can increase the risk for hospitalizations. 47 Notably, we observed differences in the relation between anxiety and readmissions depending on use of the ESAS or PHQ-4 assessments of anxiety. ESAS anxiety is a single-item measure and may lack sensitivity for significant anxiety symptoms compared with the PHQ-4, which is a well validated, multi-item tool for detecting anxiety and depression. Future studies are needed to fully explore the potential mechanisms of the associations we observed between patients' psychological symptoms and their use of health care services. However, our findings suggest that hospitalized patients with advanced cancer who experience clinically significant psychological distress represent a highly vulnerable population at risk for prolonged hospitalizations and unplanned readmissions. Consequently, strategies to screen hospitalized patients for psychological distress and provide them with adequate psychological resources should be tested in the future to improve the quality of their care.
Our work represents the largest study to date highlighting the immense symptom burden of hospitalized patients with advanced cancer. It is important to note that patients' symptoms represent a potentially modifiable risk factor that, if properly addressed, may improve health care quality and delivery. Indeed, studies have demonstrated that targeted interventions aimed at improving symptom management can enhance patient-reported outcomes. 38, 48, 49 However, most of these efforts are targeting the symptom burden of patients with cancer in the ambulatory care setting. 38, 48, 49 Hospitalized patients with advanced cancer often experience a higher symptom burden than those in the outpatient setting 30, 31 ; thus, there is a critical need to determine the efficacy of supportive care interventions in this population to reduce symptom burden and prevent excess use of health care services.
Several limitations of this study warrant discussion. First, we performed the study at a single, tertiary care site in a patient sample with limited socioeconomic diversity, which may limit the generalizability of findings to other, more diverse populations or to patients in other geographic areas. Second, it is possible that differences in illness severity and other factors could confound the relation between symptom burden and health care utilization. Nonetheless, patients' symptom burden remained a significant predictor of health care use after adjusting for potential confounders, including comorbidity, cancer type, and time since the diagnosis of advanced cancer. Third, although we report the association between symptom burden and higher health care utilization, we are unable to determine the mechanism of this association or comment on causality. Finally, we examined the relationship between patients' symptoms collected within 5 days of their admission, but we lack information regarding changes in symptom severity during hospitalization. Future research should include daily symptom assessments to understand better how patients' symptom trajectories relate to their use of health care services.
In summary, hospitalized patients with advanced cancer experience high rates of uncontrolled physical and psychological symptoms that are significantly associated with prolonged hospitalizations and a higher risk for unplanned hospital readmissions. Most, if not all, of the symptoms identified are treatable with intensive supportive care measures, which can be feasibly implemented, especially during hospital admissions. These findings highlight the critical need to monitor and address the physical and psychological symptom burden of hospitalized patients with advanced cancer. Interventions to identify and treat symptomatic patients hold great potential for improving patients' experience with their illness, enhancing their quality of life, and reducing their health care utilization. 
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